BIVDA member Oxford Nanopore Technologies have this week announced a strategic partnership with the Government, NHS England, and UK health agencies.
The partnership will utilise genomics to support the Government’s vision for a ‘fit for the future’ NHS, including by creating an ‘early warning system’ for future pandemics across as many as 30 NHS sites and improving health outcomes by targeting novel genomic and epigenomic discoveries in cancer, human genetic disease and infectious disease.
The Health and Social Care Secretary, Wes Streeting, hailed the alliance, commenting: ‘This historic partnership with Oxford Nanopore will ensure our world-leading scientists have the latest information on emerging threats at their fingertips’.
We are glad that the Government acknowledge the importance of genomics in tackling the greatest health challenges facing the country both today and tomorrow. We will continue to work with the Government and relevant stakeholders to establish similar diagnostic partnerships which develop our industry, while securing improved outcomes for patients.
